OBJECTIVE: The aim of this project was to detail the costs associated with the high prevalence mental disorders (depression, anxiety-related and substance use) in Australia, using community-based, nationally representative survey data. METHODS: Respondents diagnosed, within the preceding 12 months, with high prevalence mental disorders using the Confidentialised Unit Record Files of the 2007 National Survey of Mental Health and Wellbeing were analysed. The use of healthcare resources (hospitalisations, consultations and medications), productivity loss, income tax loss and welfare benefits were estimated. Unit costs of healthcare services were obtained from the Independent Hospital Pricing Authority, Medicare and Pharmaceutical Benefits Scheme. Labour participation rates and unemployment rates were determined from the National Survey of Mental Health and Wellbeing. Daily wage rates adjusted by age and sex were obtained from Australian Bureau of Statistics and used to estimate productivity losses. Income tax loss was estimated based on the Australian Taxation Office rates. The average cost of commonly received Government welfare benefits adjusted by age was used to estimate welfare payments. All estimates were expressed in 2013-2014 AUD and presented from multiple perspectives including public sector, individuals, private insurers, health sector and societal. RESULTS: The average annual treatment cost for people seeking treatment was AUD660 (public), AUD195 (individual), AUD1058 (private) and AUD845 from the health sector's perspective. The total annual healthcare cost was estimated at AUD974m, consisting of AUD700m to the public sector, AUD168m to individuals, and AUD107m to the private sector. The total annual productivity loss attributed to the population with high prevalence mental disorders was estimated at AUD11.8b, coupled with the yearly income tax loss at AUD1.23b and welfare payments at AUD12.9b. CONCLUSION: The population with high prevalence mental disorders not only incurs substantial cost to the Australian healthcare system but also large economic losses to society.
OBJECTIVE: The aim of this project was to detail the costs associated with the high prevalence mental disorders (depression, anxiety-related and substance use) in Australia, using community-based, nationally representative survey data. METHODS: Respondents diagnosed, within the preceding 12 months, with high prevalence mental disorders using the Confidentialised Unit Record Files of the 2007 National Survey of Mental Health and Wellbeing were analysed. The use of healthcare resources (hospitalisations, consultations and medications), productivity loss, income tax loss and welfare benefits were estimated. Unit costs of healthcare services were obtained from the Independent Hospital Pricing Authority, Medicare and Pharmaceutical Benefits Scheme. Labour participation rates and unemployment rates were determined from the National Survey of Mental Health and Wellbeing. Daily wage rates adjusted by age and sex were obtained from Australian Bureau of Statistics and used to estimate productivity losses. Income tax loss was estimated based on the Australian Taxation Office rates. The average cost of commonly received Government welfare benefits adjusted by age was used to estimate welfare payments. All estimates were expressed in 2013-2014 AUD and presented from multiple perspectives including public sector, individuals, private insurers, health sector and societal. RESULTS: The average annual treatment cost for people seeking treatment was AUD660 (public), AUD195 (individual), AUD1058 (private) and AUD845 from the health sector's perspective. The total annual healthcare cost was estimated at AUD974m, consisting of AUD700m to the public sector, AUD168m to individuals, and AUD107m to the private sector. The total annual productivity loss attributed to the population with high prevalence mental disorders was estimated at AUD11.8b, coupled with the yearly income tax loss at AUD1.23b and welfare payments at AUD12.9b. CONCLUSION: The population with high prevalence mental disorders not only incurs substantial cost to the Australian healthcare system but also large economic losses to society.
Entities:
Keywords:
Australia; Cost-of-illness; NSMHWB 2007; National Survey of Mental Health and Wellbeing 2007; anxiety disorders; cost; depression; substance use disorders
Authors: Yong Yi Lee; Cathrine Mihalopoulos; Mary Lou Chatterton; Susan L Fletcher; Patty Chondros; Konstancja Densley; Elizabeth Murray; Christopher Dowrick; Amy Coe; Kelsey L Hegarty; Sandra K Davidson; Caroline Wachtler; Victoria J Palmer; Jane M Gunn Journal: PLoS One Date: 2022-05-25 Impact factor: 3.752
Authors: Louise Birrell; Nicola C Newton; Tim Slade; Catherine Chapman; Louise Mewton; Nyanda McBride; Leanne Hides; Mary Lou Chatterton; Steve Allsop; Annalise Healy; Marius Mather; Catherine Quinn; Cathrine Mihalopoulos; Maree Teesson Journal: JMIR Res Protoc Date: 2018-11-06
Authors: Yiwang Zhou; Lu Zhao; Nina Zhou; Yi Zhao; Simeone Marino; Tuo Wang; Hanbo Sun; Arthur W Toga; Ivo D Dinov Journal: Sci Rep Date: 2019-04-12 Impact factor: 4.379
Authors: Carole James; Ross Tynan; Della Roach; Lucy Leigh; Christopher Oldmeadow; Mijanur Rahman; Brian Kelly Journal: PLoS One Date: 2018-12-20 Impact factor: 3.240
Authors: Long Khanh-Dao Le; Lena Sanci; Mary Lou Chatterton; Sylvia Kauer; Kerrie Buhagiar; Cathrine Mihalopoulos Journal: J Med Internet Res Date: 2019-07-22 Impact factor: 5.428
Authors: Sharon Lawn; Nancy Huang; Sara Zabeen; David Smith; Malcolm Battersby; Paula Redpath; Fiona Glover; Anthony Venning; Jane Cameron; Kate Fairweather-Schmidt Journal: BMC Psychiatry Date: 2019-01-03 Impact factor: 3.630